PIEZO2 deficiency is a recognizable arthrogryposis syndrome: A new case and literature review

Tomomi Yamaguchi, Kyoko Takano, Yuji Inaba, Manami Morikawa, Mitsuo Motobayashi, Rie Kawamura, Keiko Wakui, Eriko Nishi, Shin ichi Hirabayashi, Yoshimitsu Fukushima, Hiroyuki Kato, Jun Takahashi, Tomoki Kosho

Research output: Contribution to journalArticle

Abstract

PIEZO2 encodes a mechanically activated cation channel, which is abundantly expressed in dorsal root ganglion neuron and sensory endings of proprioceptors required for light touch sensation and proprioception in mice. Biallelic loss-of-function mutations in PIEZO2 (i.e., PIEZO2 deficiency) were recently found to cause an arthrogryposis syndrome. Sixteen patients from eight families have been reported to date. Herein we report a new case, including detailed clinical characteristics and courses as well as comprehensive neurological features. The patient was a 12-year-old girl presenting with congenital multiple contractures, progressive severe scoliosis, prenatal-onset growth impairment, motor developmental delay with hypotonia and myopathy-like muscle pathology, mild facial features, and normal intelligence. Her neurological features included areflexia, impaired proprioception, and decreased senses. Neurophysiological examination revealed decreased amplitude of sensory nerve action potentials, absent H reflex, and prolongation of central conduction times. Clinical exome sequencing revealed a novel homozygous frameshift mutation in PIEZO2 (NM_022068: c.4171_4174delGTCA: p.Val1391Lysfs*39) with no detectable mRNA expression of the gene. PIEZO2 deficiency represents a clinical entity involving characteristic neuromuscular abnormalities and physical features. Next generation sequencing-based comprehensive molecular screening and extensive neurophysiological examination could be valuable for diagnosis of the disorder.

Original languageEnglish
Pages (from-to)948-957
Number of pages10
JournalAmerican Journal of Medical Genetics, Part A
Volume179
Issue number6
DOIs
Publication statusPublished - 01-06-2019

Fingerprint

Arthrogryposis
Proprioception
Exome
H-Reflex
Abnormal Reflexes
Frameshift Mutation
Muscle Hypotonia
Touch
Spinal Ganglia
Scoliosis
Contracture
Sensory Receptor Cells
Muscular Diseases
Intelligence
Action Potentials
Cations
Pathology
Gene Expression
Muscles
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Yamaguchi, Tomomi ; Takano, Kyoko ; Inaba, Yuji ; Morikawa, Manami ; Motobayashi, Mitsuo ; Kawamura, Rie ; Wakui, Keiko ; Nishi, Eriko ; Hirabayashi, Shin ichi ; Fukushima, Yoshimitsu ; Kato, Hiroyuki ; Takahashi, Jun ; Kosho, Tomoki. / PIEZO2 deficiency is a recognizable arthrogryposis syndrome : A new case and literature review. In: American Journal of Medical Genetics, Part A. 2019 ; Vol. 179, No. 6. pp. 948-957.
@article{7e7828ea77894c34a0b2e2c46ac29c05,
title = "PIEZO2 deficiency is a recognizable arthrogryposis syndrome: A new case and literature review",
abstract = "PIEZO2 encodes a mechanically activated cation channel, which is abundantly expressed in dorsal root ganglion neuron and sensory endings of proprioceptors required for light touch sensation and proprioception in mice. Biallelic loss-of-function mutations in PIEZO2 (i.e., PIEZO2 deficiency) were recently found to cause an arthrogryposis syndrome. Sixteen patients from eight families have been reported to date. Herein we report a new case, including detailed clinical characteristics and courses as well as comprehensive neurological features. The patient was a 12-year-old girl presenting with congenital multiple contractures, progressive severe scoliosis, prenatal-onset growth impairment, motor developmental delay with hypotonia and myopathy-like muscle pathology, mild facial features, and normal intelligence. Her neurological features included areflexia, impaired proprioception, and decreased senses. Neurophysiological examination revealed decreased amplitude of sensory nerve action potentials, absent H reflex, and prolongation of central conduction times. Clinical exome sequencing revealed a novel homozygous frameshift mutation in PIEZO2 (NM_022068: c.4171_4174delGTCA: p.Val1391Lysfs*39) with no detectable mRNA expression of the gene. PIEZO2 deficiency represents a clinical entity involving characteristic neuromuscular abnormalities and physical features. Next generation sequencing-based comprehensive molecular screening and extensive neurophysiological examination could be valuable for diagnosis of the disorder.",
author = "Tomomi Yamaguchi and Kyoko Takano and Yuji Inaba and Manami Morikawa and Mitsuo Motobayashi and Rie Kawamura and Keiko Wakui and Eriko Nishi and Hirabayashi, {Shin ichi} and Yoshimitsu Fukushima and Hiroyuki Kato and Jun Takahashi and Tomoki Kosho",
year = "2019",
month = "6",
day = "1",
doi = "10.1002/ajmg.a.61142",
language = "English",
volume = "179",
pages = "948--957",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "6",

}

Yamaguchi, T, Takano, K, Inaba, Y, Morikawa, M, Motobayashi, M, Kawamura, R, Wakui, K, Nishi, E, Hirabayashi, SI, Fukushima, Y, Kato, H, Takahashi, J & Kosho, T 2019, 'PIEZO2 deficiency is a recognizable arthrogryposis syndrome: A new case and literature review', American Journal of Medical Genetics, Part A, vol. 179, no. 6, pp. 948-957. https://doi.org/10.1002/ajmg.a.61142

PIEZO2 deficiency is a recognizable arthrogryposis syndrome : A new case and literature review. / Yamaguchi, Tomomi; Takano, Kyoko; Inaba, Yuji; Morikawa, Manami; Motobayashi, Mitsuo; Kawamura, Rie; Wakui, Keiko; Nishi, Eriko; Hirabayashi, Shin ichi; Fukushima, Yoshimitsu; Kato, Hiroyuki; Takahashi, Jun; Kosho, Tomoki.

In: American Journal of Medical Genetics, Part A, Vol. 179, No. 6, 01.06.2019, p. 948-957.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PIEZO2 deficiency is a recognizable arthrogryposis syndrome

T2 - A new case and literature review

AU - Yamaguchi, Tomomi

AU - Takano, Kyoko

AU - Inaba, Yuji

AU - Morikawa, Manami

AU - Motobayashi, Mitsuo

AU - Kawamura, Rie

AU - Wakui, Keiko

AU - Nishi, Eriko

AU - Hirabayashi, Shin ichi

AU - Fukushima, Yoshimitsu

AU - Kato, Hiroyuki

AU - Takahashi, Jun

AU - Kosho, Tomoki

PY - 2019/6/1

Y1 - 2019/6/1

N2 - PIEZO2 encodes a mechanically activated cation channel, which is abundantly expressed in dorsal root ganglion neuron and sensory endings of proprioceptors required for light touch sensation and proprioception in mice. Biallelic loss-of-function mutations in PIEZO2 (i.e., PIEZO2 deficiency) were recently found to cause an arthrogryposis syndrome. Sixteen patients from eight families have been reported to date. Herein we report a new case, including detailed clinical characteristics and courses as well as comprehensive neurological features. The patient was a 12-year-old girl presenting with congenital multiple contractures, progressive severe scoliosis, prenatal-onset growth impairment, motor developmental delay with hypotonia and myopathy-like muscle pathology, mild facial features, and normal intelligence. Her neurological features included areflexia, impaired proprioception, and decreased senses. Neurophysiological examination revealed decreased amplitude of sensory nerve action potentials, absent H reflex, and prolongation of central conduction times. Clinical exome sequencing revealed a novel homozygous frameshift mutation in PIEZO2 (NM_022068: c.4171_4174delGTCA: p.Val1391Lysfs*39) with no detectable mRNA expression of the gene. PIEZO2 deficiency represents a clinical entity involving characteristic neuromuscular abnormalities and physical features. Next generation sequencing-based comprehensive molecular screening and extensive neurophysiological examination could be valuable for diagnosis of the disorder.

AB - PIEZO2 encodes a mechanically activated cation channel, which is abundantly expressed in dorsal root ganglion neuron and sensory endings of proprioceptors required for light touch sensation and proprioception in mice. Biallelic loss-of-function mutations in PIEZO2 (i.e., PIEZO2 deficiency) were recently found to cause an arthrogryposis syndrome. Sixteen patients from eight families have been reported to date. Herein we report a new case, including detailed clinical characteristics and courses as well as comprehensive neurological features. The patient was a 12-year-old girl presenting with congenital multiple contractures, progressive severe scoliosis, prenatal-onset growth impairment, motor developmental delay with hypotonia and myopathy-like muscle pathology, mild facial features, and normal intelligence. Her neurological features included areflexia, impaired proprioception, and decreased senses. Neurophysiological examination revealed decreased amplitude of sensory nerve action potentials, absent H reflex, and prolongation of central conduction times. Clinical exome sequencing revealed a novel homozygous frameshift mutation in PIEZO2 (NM_022068: c.4171_4174delGTCA: p.Val1391Lysfs*39) with no detectable mRNA expression of the gene. PIEZO2 deficiency represents a clinical entity involving characteristic neuromuscular abnormalities and physical features. Next generation sequencing-based comprehensive molecular screening and extensive neurophysiological examination could be valuable for diagnosis of the disorder.

UR - http://www.scopus.com/inward/record.url?scp=85063813704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063813704&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.61142

DO - 10.1002/ajmg.a.61142

M3 - Article

AN - SCOPUS:85063813704

VL - 179

SP - 948

EP - 957

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 6

ER -